Financials • Specialty Insurers
$82.19 ▲ +0.61
(+0.75%)
MKT CAP: $4.15B • VOL: 125.6K
52W L $45 52W H $85
ROARABLE / RQD
C • 64/100
PIOTROSKI
7 / 9
CRVL // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $958.5M | $895.6M | $795.3M |
| YoY Revenue Growth % | +7.0% | +12.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $110.3M | $95.2M | $76.3M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $155.6M | $127.3M | $99.2M |
| Capital Expenditures (CapEx) | $45.4M | $35.8M | — |
| Free Cash Flow (FCF) | $110.3M | $91.6M | $99.2M |
| FCF Margin % | 11.5% | 10.2% | 12.5% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $230.0M | $162.9M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $375.7M | $300.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CRVL.